Getinge Life Science President Eric Honroth to step down Oct. 31, 2026
Bitget2026/10/07 12:45Getinge set Oct. 31, 2026 as the departure date for Eric Honroth as President, Life Science. He previously led North America Sales before taking the Life Science role. An internal leader will step in as acting President, Life Science from Nov. 1. The group started a search for a permanent successor, weighing internal candidates alongside external options. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Getinge AB published the original content used to generate this news brief via Cision (Ref. ID: 20261007:BIT:0288:0) on October 07, 2026, and is solely responsible for the information contained therein.
- Getinge set Oct. 31, 2026 as the departure date for Eric Honroth as President, Life Science.
- He previously led North America Sales before taking the Life Science role.
- An internal leader will step in as acting President, Life Science from Nov. 1.
- The group started a search for a permanent successor, weighing internal candidates alongside external options.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
SNT Holdings, Related Party Raise Combined Stake in SNTEnergy to 55.75% From 52.75%
Cold wave and rising fuel costs drive electricity prices in northeastern Japan and Tokyo to a four-year high
Japan's spot electricity prices surged to multi-year highs over the weekend.

Google (GOOGL.US) warns that new Australian cybersecurity regulations may cut off minors' access to Gmail
Google stated that a new cybersecurity bill in Australia could prevent minors from using Gmail.

Canaccord Genuity: Lowers Oklo's target price to $66